Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QF48
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 2 |
GO:0005509 | calcium ion binding | 5 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043169 | cation binding | 3 | 2 |
GO:0046872 | metal ion binding | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 54 | 58 | PF00656 | 0.614 |
CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.404 |
CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.451 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.497 |
CLV_NRD_NRD_1 | 366 | 368 | PF00675 | 0.673 |
CLV_PCSK_KEX2_1 | 118 | 120 | PF00082 | 0.403 |
CLV_PCSK_KEX2_1 | 132 | 134 | PF00082 | 0.454 |
CLV_PCSK_KEX2_1 | 16 | 18 | PF00082 | 0.516 |
CLV_PCSK_KEX2_1 | 366 | 368 | PF00082 | 0.673 |
CLV_PCSK_PC1ET2_1 | 16 | 18 | PF00082 | 0.455 |
CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.411 |
CLV_PCSK_SKI1_1 | 121 | 125 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 17 | 21 | PF00082 | 0.541 |
CLV_PCSK_SKI1_1 | 277 | 281 | PF00082 | 0.592 |
CLV_PCSK_SKI1_1 | 300 | 304 | PF00082 | 0.583 |
DEG_Kelch_Keap1_1 | 230 | 235 | PF01344 | 0.602 |
DEG_SCF_TRCP1_1 | 57 | 63 | PF00400 | 0.585 |
DOC_CYCLIN_RxL_1 | 139 | 148 | PF00134 | 0.516 |
DOC_MAPK_gen_1 | 16 | 24 | PF00069 | 0.525 |
DOC_MAPK_gen_1 | 300 | 310 | PF00069 | 0.657 |
DOC_MAPK_MEF2A_6 | 303 | 312 | PF00069 | 0.639 |
DOC_MAPK_NFAT4_5 | 303 | 311 | PF00069 | 0.638 |
DOC_PP4_FxxP_1 | 181 | 184 | PF00568 | 0.620 |
DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.480 |
DOC_USP7_MATH_1 | 177 | 181 | PF00917 | 0.602 |
DOC_USP7_MATH_1 | 188 | 192 | PF00917 | 0.448 |
DOC_USP7_UBL2_3 | 16 | 20 | PF12436 | 0.532 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.616 |
DOC_WW_Pin1_4 | 250 | 255 | PF00397 | 0.468 |
DOC_WW_Pin1_4 | 81 | 86 | PF00397 | 0.514 |
LIG_14-3-3_CanoR_1 | 239 | 243 | PF00244 | 0.517 |
LIG_14-3-3_CterR_2 | 366 | 371 | PF00244 | 0.618 |
LIG_Actin_WH2_2 | 105 | 123 | PF00022 | 0.522 |
LIG_Actin_WH2_2 | 12 | 27 | PF00022 | 0.434 |
LIG_BRCT_BRCA1_1 | 252 | 256 | PF00533 | 0.436 |
LIG_FHA_1 | 107 | 113 | PF00498 | 0.444 |
LIG_FHA_1 | 262 | 268 | PF00498 | 0.446 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.572 |
LIG_FHA_2 | 281 | 287 | PF00498 | 0.582 |
LIG_FHA_2 | 52 | 58 | PF00498 | 0.605 |
LIG_FHA_2 | 6 | 12 | PF00498 | 0.563 |
LIG_FHA_2 | 82 | 88 | PF00498 | 0.499 |
LIG_HCF-1_HBM_1 | 325 | 328 | PF13415 | 0.656 |
LIG_IRF3_LxIS_1 | 306 | 313 | PF10401 | 0.480 |
LIG_LIR_Apic_2 | 178 | 184 | PF02991 | 0.631 |
LIG_LIR_Apic_2 | 325 | 331 | PF02991 | 0.641 |
LIG_LIR_Gen_1 | 147 | 157 | PF02991 | 0.528 |
LIG_LIR_Gen_1 | 244 | 252 | PF02991 | 0.377 |
LIG_LIR_Gen_1 | 316 | 327 | PF02991 | 0.571 |
LIG_LIR_Nem_3 | 147 | 152 | PF02991 | 0.508 |
LIG_LIR_Nem_3 | 241 | 245 | PF02991 | 0.390 |
LIG_LIR_Nem_3 | 348 | 352 | PF02991 | 0.523 |
LIG_LRP6_Inhibitor_1 | 4 | 10 | PF00058 | 0.637 |
LIG_RPA_C_Fungi | 114 | 126 | PF08784 | 0.452 |
LIG_SH2_CRK | 249 | 253 | PF00017 | 0.417 |
LIG_SH2_PTP2 | 328 | 331 | PF00017 | 0.548 |
LIG_SH2_SRC | 328 | 331 | PF00017 | 0.559 |
LIG_SH2_STAP1 | 242 | 246 | PF00017 | 0.504 |
LIG_SH2_STAT5 | 245 | 248 | PF00017 | 0.435 |
LIG_SH2_STAT5 | 301 | 304 | PF00017 | 0.649 |
LIG_SH2_STAT5 | 328 | 331 | PF00017 | 0.537 |
LIG_SH2_STAT5 | 349 | 352 | PF00017 | 0.522 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.390 |
LIG_SH3_1 | 328 | 334 | PF00018 | 0.547 |
LIG_SH3_3 | 161 | 167 | PF00018 | 0.566 |
LIG_SH3_3 | 328 | 334 | PF00018 | 0.522 |
LIG_SUMO_SIM_par_1 | 292 | 297 | PF11976 | 0.542 |
LIG_WRC_WIRS_1 | 146 | 151 | PF05994 | 0.448 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.529 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.445 |
MOD_CK1_1 | 313 | 319 | PF00069 | 0.547 |
MOD_CK1_1 | 55 | 61 | PF00069 | 0.679 |
MOD_CK2_1 | 238 | 244 | PF00069 | 0.468 |
MOD_CK2_1 | 280 | 286 | PF00069 | 0.612 |
MOD_CK2_1 | 5 | 11 | PF00069 | 0.579 |
MOD_CK2_1 | 81 | 87 | PF00069 | 0.467 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.520 |
MOD_GlcNHglycan | 136 | 139 | PF01048 | 0.610 |
MOD_GlcNHglycan | 215 | 218 | PF01048 | 0.706 |
MOD_GlcNHglycan | 232 | 235 | PF01048 | 0.536 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.694 |
MOD_GlcNHglycan | 99 | 102 | PF01048 | 0.547 |
MOD_GSK3_1 | 106 | 113 | PF00069 | 0.454 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.522 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.669 |
MOD_GSK3_1 | 313 | 320 | PF00069 | 0.534 |
MOD_GSK3_1 | 341 | 348 | PF00069 | 0.593 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.643 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.534 |
MOD_N-GLC_1 | 317 | 322 | PF02516 | 0.542 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.528 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.433 |
MOD_NEK2_1 | 189 | 194 | PF00069 | 0.463 |
MOD_NEK2_1 | 280 | 285 | PF00069 | 0.594 |
MOD_NEK2_1 | 310 | 315 | PF00069 | 0.605 |
MOD_NEK2_1 | 341 | 346 | PF00069 | 0.566 |
MOD_PKA_2 | 213 | 219 | PF00069 | 0.563 |
MOD_PKA_2 | 238 | 244 | PF00069 | 0.521 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.578 |
MOD_Plk_1 | 317 | 323 | PF00069 | 0.544 |
MOD_Plk_1 | 5 | 11 | PF00069 | 0.613 |
MOD_Plk_2-3 | 238 | 244 | PF00069 | 0.528 |
MOD_Plk_4 | 207 | 213 | PF00069 | 0.609 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.608 |
MOD_ProDKin_1 | 250 | 256 | PF00069 | 0.467 |
MOD_ProDKin_1 | 81 | 87 | PF00069 | 0.509 |
TRG_ENDOCYTIC_2 | 245 | 248 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 249 | 252 | PF00928 | 0.383 |
TRG_ENDOCYTIC_2 | 319 | 322 | PF00928 | 0.645 |
TRG_ENDOCYTIC_2 | 349 | 352 | PF00928 | 0.580 |
TRG_ER_diArg_1 | 118 | 121 | PF00400 | 0.457 |
TRG_ER_diArg_1 | 17 | 19 | PF00400 | 0.489 |
TRG_NLS_MonoExtC_3 | 15 | 20 | PF00514 | 0.426 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCG2 | Leptomonas seymouri | 56% | 100% |
A0A0S4JMV6 | Bodo saltans | 29% | 100% |
A0A1X0NUM9 | Trypanosomatidae | 37% | 100% |
A0A3R7MLD6 | Trypanosoma rangeli | 35% | 100% |
A0A3S7WTM7 | Leishmania donovani | 93% | 100% |
A4H897 | Leishmania braziliensis | 75% | 100% |
A4HWL9 | Leishmania infantum | 92% | 100% |
E9AQC6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
V5BUD9 | Trypanosoma cruzi | 34% | 100% |